Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-07-28

Clinical Trial Update: CARotid plaqUe StabilizatiOn and Regression With Evolocumab. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update exploring evolocumab for stabilization and regression of carotid plaque.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Evolocumab (evolocumab)

Snippet

Sponsor: Azienda Ospedaliera Ordine Mauriziano di Torino | Conditions: Carotid Artery Disease | Phase 4 | Status: UNKNOWN